Summary of Purpose
To assess whether a selective serotonin reuptake inhibitor is effective in the treatment of stroke-associated lability of mood.Read More →
The following dates are available for this trial. Trial information last updated on 21 September 2001.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Double-blind, randomized, placebo-controlled, parallel group trial of 28 patients at 3 centers.
Alistair Burns, Department of Old Age Psychiatry, Withington Hospital, West Didsbury, Manchester M20 8LR, UK.A_Burns@fs1.with.man.ac.uk